Gilead Sciences (GILD) Retained Earnings (2009 - 2026)
Gilead Sciences (GILD) reported Retained Earnings of $2.2 billion for Q2 2026, down 80.6% from $11.33 billion a year earlier and down 84.4% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Retained Earnings (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences posted Retained Earnings of $13.73 billion, up 19.4% from FY2024.
- Retained Earnings has a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
- By year, Retained Earnings came in at $11.5 billion in FY2024 (-29.5%), $16.3 billion in FY2023 (+3.9%), $15.69 billion in FY2022 (-3.9%) and $16.32 billion in FY2021 (+13.5%).
- The Q2 2026 figure ranks as the lowest quarterly Retained Earnings since Q1 2012.
- Year over year, Retained Earnings gained in five of the last eight quarters, with an average decline of 9.0%.
- The high point for year-over-year Retained Earnings in five years was Q1 2026 (growth of 29.3%); the low point was Q2 2026 (a decline of 80.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.13 billion (Q1 2026), $13.73 billion (Q4 2025) and $12.83 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 20.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.20 Bn |
| Mar 31, 2026 | 14.13 Bn |
| Dec 31, 2025 | 13.73 Bn |
| Sep 30, 2025 | 12.83 Bn |
| Jun 30, 2025 | 11.33 Bn |
| Mar 31, 2025 | 10.93 Bn |
| Dec 31, 2024 | 11.50 Bn |
| Sep 30, 2024 | 11.07 Bn |
| Jun 30, 2024 | 11.17 Bn |
| Mar 31, 2024 | 10.66 Bn |
| Dec 31, 2023 | 16.30 Bn |
| Sep 30, 2023 | 16.00 Bn |
| Jun 30, 2023 | 15.14 Bn |
| Mar 31, 2023 | 15.22 Bn |
| Dec 31, 2022 | 15.69 Bn |
| Sep 30, 2022 | 15.76 Bn |
| Jun 30, 2022 | 15.12 Bn |
| Mar 31, 2022 | 14.99 Bn |
| Dec 31, 2021 | 16.32 Bn |
| Sep 30, 2021 | 16.90 Bn |
API Access
Gilead Sciences Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();